(Q37763495)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531299%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

Lung cancer stem cells: tools and targets to fight lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531299%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

main subject

neoplastic stem cells

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531299%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Tobias L Haas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531299%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

R De Maria

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531299%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

7 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531299%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531299%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531299%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531299%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

4625-4635

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531299%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2010.207

5 February 2020

exact match

0 references

cites work

Unbiased vs. biased approaches to the identification of cancer signatures: the case of lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

IL-4-mediated drug resistance in colon cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Prospective identification of tumorigenic breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Crypt stem cells as the cells-of-origin of intestinal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

31 March 2020

The intestinal stem cell

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

The evolving concept of a stem cell: entity or function?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Proliferation of respiratory tract epithelium in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

31 March 2020

Genomics of lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

A perivascular niche for brain tumor stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Phenotypic characterization of human colorectal cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Update in lung cancer 2007

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Update in lung cancer 2008

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Identification and expansion of the tumorigenic lung cancer stem cell population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

The tortoise and the hair: slow-cycling cells in the stem cell race

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Stem cells are dispensable for lung homeostasis but restore airways after injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Lung cancer and lung stem cells: strange bedfellows?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Identification of selective inhibitors of cancer stem cells by high-throughput screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Identifying cancer stem cells in solid tumors: case not proven

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

In vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Myeloid lineage commitment from the hematopoietic stem cell

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Identification of bronchioalveolar stem cells in normal lung and lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Reconstruction of functionally normal and malignant human breast tissues in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Pulmonary preneoplasia--sequential molecular carcinogenetic events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Isolation of neural stem cells from the postnatal cerebellum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Hematopoiesis and stem cells: plasticity versus developmental heterogeneity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

31 March 2020

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Lung epithelial progenitor cells: lessons from development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Stem cells, cancer, and cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Identification and expansion of human colon-cancer-initiating cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

KRAS mutations in non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Circulating and disseminated tumor cells in the management of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Identification and targeting of cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Molecular genetics of lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Identification of human brain tumour initiating cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Whole cell sodium conductance of principal cells freshly isolated from rat cortical collecting duct

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Maintenance and repair of the bronchiolar epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Cancer stem cells: lessons from leukemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

let-7 regulates self renewal and tumorigenicity of breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Stem cell marker CD133 affects clinical outcome in glioma patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.207